Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.59 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11274656 | 1.00 | TSHR (0.68) | TSHRMKNK1MKNK2TAAR1HTT | |
| Biphenyl SCHEMBL27280595 | 1.00 | TSHR (0.68) | TSHRMKNK1MKNK2TAAR1HTT | |
| SCHEMBL15043308 | 0.93 | TSHR (0.59) | TSHRMKNK1MKNK2TAAR1HTT | |
| Biphenyl SCHEMBL3279732 | 0.92 | TSHR (0.82) | TSHRMKNK1MKNK2TAAR1HTT | |
| SCHEMBL35773 | 0.90 | TSHR (0.62) | TSHRMKNK1MKNK2TAAR1HTT | |
| SCHEMBL679970 | 0.88 | MKNK1 (0.56) | TSHRMKNK1MKNK2HTTABCC4 | |
| SCHEMBL11310791 | 0.88 | MKNK1 (0.56) | TSHRMKNK1MKNK2HTTABCC4 | |
| SCHEMBL10610530 | 0.87 | TSHR (0.52) | TSHRMKNK1MKNK2TAAR1HTT | |
| SCHEMBL21993468 | 0.87 | LTA4H (0.80) | TSHRMKNK1MKNK2TAAR1HTT | |
| SCHEMBL12191267 | 0.87 | TSHR (0.52) | TSHRMKNK1MKNK2TAAR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1080 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081969-A | VSe-Cu2-xSe nanosheet catalysis C (sp)3) -H bond CO2Method for directionally synthesizing alpha-hydroxy/amino acid by carboxylation | — | 2026-05-26 | — | — | CN | claimed |
| US-12612479-B2 | Cross-linkable compositions having a low viscosity for coatings and materials with a high refractive index and a high heat deflection temperature | ARKEMA FRANCE (FR) | 2026-04-28 | — | — | US | claimed |
| CN-117005198-B | Short carbon chain fluorine-containing finishing agent and preparation and application thereof | 德雄实业(浙江)有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119661322-A | Synthesis method of 4-diphenyl methanol | 河北科技大学 | 2025-03-21 | — | — | CN | claimed |
| CN-116063153-B | Synthesis method of 4-diphenyl methanol | 中国科学院大连化学物理研究所 | 2025-03-14 | — | — | CN | claimed |
| CN-119487102-A | Apparatus and efficient method for producing polylactic acid using lactide obtained from devolatilization of polylactic acid | 苏尔寿管理有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-4496827-A1 | A PLANT AND AN EFFICIENT PROCESS FOR PRODUCING POLYLACTIC ACID USING LACTIDE OBTAINED FROM POLYLACTIC ACID DEVOLATILIZATION | Sulzer Management AG (CH) | 2025-01-29 | — | — | EP | claimed |
| EP-4496828-A1 | A PLANT AND AN EFFICIENT PROCESS FOR PRODUCING POLYLACTIC ACID | Sulzer Management AG (CH) | 2025-01-29 | — | — | EP | claimed |
| CN-119137185-A | Oligomeric binaphthyl compounds and thermoplastic resins | 三菱瓦斯化学株式会社 | 2024-12-13 | — | — | CN | claimed |
| EP-3778722-B1 | POLYCARBONATE RESIN COMPOSITION PELLET, PELLET PRODUCTION METHOD AND MOLDED ACTICLE THEREOF | MITSUBISHI ENG PLASTICS CORP (JP) | 2024-12-11 | — | — | EP | claimed |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| US-20020165231-A1 | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| US-20020068736-A1 | Biphenyl compounds and their use as oestrogenic agents | LESUISSE DOMINIQUE (FR) | 2002-06-06 | — | — | US | claimed |
| US-6288126-B1 | Biphenyl compounds and use thereof as oestrogenic agents | AVENTIS PHARMA S.A. | 2001-09-11 | — | — | US | claimed |
| EP-1115693-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000018721-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| EP-0877607-A1 | BIPHENYL COMPOUNDS AND USE THEREOF AS OESTROGENIC AGENTS | HOECHST MARION ROUSSEL (FR) | 1998-11-18 | — | — | EP | claimed |
| WO-1997027846-A1 | BIPHENYL COMPOUNDS AND USE THEREOF AS OESTROGENIC AGENTS | HOECHST MARION ROUSSEL (FR) | 1997-08-07 | — | — | WO | claimed |
| US-5043312-A | Mixture of imino and isocyanate compounds, biphenyl alcohol in binder on support; image preservation, heat responsiveness | MITSUBISHI PAPER MILLS LIMITED (JP) | 1991-08-27 | — | — | US | claimed |
| US-4613622-A | Sebosuppressive preparations containing benzyl alcohol derivatives | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1986-09-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068736-A1 | Biphenyl compounds and their use as oestrogenic agents | ESR2, ESR1, CYP19A1 | TSHR 451/4885MKNK1 4331/4885MKNK2 3885/4885 |
| US-20020165231-A1 | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, LCAT, MTTP | TSHR 4233/4885MKNK1 3426/4885MKNK2 3720/4885 |
| US-12612479-B2 | Cross-linkable compositions having a low viscosity for coatings and materials with a high refractive index and a high heat deflection temperature | MACF1, HTR3D, CD40 | TSHR 1777/4885MKNK1 2001/4885MKNK2 1921/4885 |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, DBI, PLTP | TSHR 4329/4885MKNK1 3247/4885MKNK2 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.